Address
Email address
Phone number
Website
Medex päevakirurgia erakliinik võtab patsiente vastu Tartu kliinikus ja Tallinna kabinetis. Ortopeedi vastuvõtt, luu- ja liigesehaiguste diagnostika ja ravi, liigesevigastuste endoskoopiline diagnostika ja kirurgiline ravi, operatsioonijärgne taastusravi, sobiva liigestoe (ortoosi) määramine. Medex on Eesti Tervisekassa lepingupartner.
Name
aktsiaselts MEDEX
Registry code
10080187
Type
AS - Joint Stock Company
Status
Registered
Foundation date
13.08.1996 (28)
Financial year
01.01-31.12
Capital
30 672.00 €
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
-
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
ERREM INVEST OÜ 16471822 | 100% - 30 672.00 EUR | - | - | Shareholder |
Liis Pruusapuu
| - | Board member | - | |
Risto Tralla
| - | - | - | Board member |
Tõnu Kõnd
| - | - | - | Board member |
Omanikukonto: Margus Kõnd
| - | - | - | Chairman of the board |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
OÜ Kalevi KV 16464658 | - | - | - | Founder |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q4 | - | 32 856.11 € | 35 010.53 € | 21 |
2024 Q3 | - | 39 026.27 € | 41 508.99 € | 21 |
2024 Q2 | - | 30 466.3 € | 32 387.81 € | 21 |
2024 Q1 | - | 26 763.82 € | 28 587.42 € | 21 |
2023 Q4 | - | 28 708.96 € | 30 666.29 € | 19 |
2023 Q3 | - | 35 019.74 € | 37 324.84 € | 28 |
2023 Q2 | - | 29 992.21 € | 31 927.03 € | 28 |
2023 Q1 | - | 25 395.34 € | 27 041.63 € | 28 |
2022 Q4 | - | 23 980.65 € | 25 553.82 € | 28 |
2022 Q3 | - | 28 403.36 € | 30 223.24 € | 29 |
2022 Q2 | - | 32 161.37 € | 26 732.92 € | 27 |
2022 Q1 | - | 24 719.66 € | 26 247.99 € | 31 |
2021 Q4 | 362.25 € | 26 388.29 € | 27 866.27 € | 31 |
2021 Q3 | - | 30 367.64 € | 32 320.58 € | 31 |
2021 Q2 | 833 333.33 € | 193 071.4 € | 28 156.57 € | 32 |
2021 Q1 | - | 57 081.96 € | 28 854.38 € | 32 |
2020 Q4 | - | 28 981.99 € | 30 868.11 € | 36 |
2020 Q3 | - | 25 409.61 € | 27 228.67 € | 38 |
2020 Q2 | - | 13 470.38 € | 14 448.35 € | 39 |
2020 Q1 | - | 27 045.58 € | 28 901.45 € | 41 |